Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
FGFR2 promotes resistance to ALK tyrosine kinase inhibito... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
FGFR2 promotes resistance to ALK tyrosine kinase inhibitors and its inhibition acts synergistically with lorlatinib in the treatment of ALK-expressing neuroblastoma
0
Authors
Perla Pucci
15 more
Perla Pucci
•
Charlotte Barrett
13 more
•
Suzanne Turner
Published
September 10, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Chemistry
Medicine
Cancer Oncology
Show all topics
DOI
10.1101/2024.09.05.611416
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Chemistry
Medicine
Cancer Oncology
Show all topics
DOI
10.1101/2024.09.05.611416
License
cc-no
